Skip to content

A study to evaluate the efficacy of Tintrinyadi kashaya in Iron defeciency anaemia .

A randomized open labelled controlled clinical study to evaluate the efficacy of Tintrinyadi kashaya in the management of Pandu with special reference to Iron defeciency anaemia.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/053270
Enrollment
30
Registered
2023-05-30
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D509- Iron deficiency anemia, unspecified

Interventions

None listed

Sponsors

Dr Megha Venkatraman Hegde
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects of either gender between the age group of 21-60 years Subjects who full fill the diagnostic criteria. Subjects willing to participate with written informed consent, which is conveyed in the language, which the subject can understand. Freshly diagnosed case

Exclusion criteria

Exclusion criteria: Pregnant and Lactating women. Diagnosed case of thalassemia ,sickle cell anaemia ,megaloblastic anemia,haemolytic anaemia . Subjects with any uncontrolled systemic illness like Diabetes Mellitus,Hypertension etc which interefere with course of disease and course of treatment will be excluded .

Design outcomes

Primary

MeasureTime frame
Improvement in Hb %Timepoint: before intervention- 0th day during intervention- 15th day after intervention- 30th day follow up- 45th day

Secondary

MeasureTime frame
Reduction in the symptoms of Panduta(pallor ) Pindikodvestana (cramps in calf muscles) Bhrama( giddiness) Hridspandana(palpitation ) Dourbalya(weakness ) Arohana Aayasa( exertional dyspnea) Gatra shoola(generalised body pain ) Timepoint: 0th day - Pretest assessment â?? pre test assessment of subjective parameters & objective parameters. 15th day - assessment of subjective parameters during trial period . 30th day -assessment of subjective parameters & Hb% , during trial period . 45 th day - Follow up assessment of subjective parameters and Hb% .

Countries

India

Contacts

Public ContactDr Megha Venkatraman Hegde

Sri sri college of ayurvedic science and research

lakshmimp1981@gmail.com9448173128

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026